ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 2056

$454K Total Retail Price of All Prescriptions

Rank: 97 out of 2056

624 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

15% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,222 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 526 494 1 2
OMEPRAZOLE 440 404 2 4
ATENOLOL 406 381 3 10
LISINOPRIL 405 388 4 1
K-TAB 295 287 5 57
HYDROCODONE-ACETAMINOPHEN 253 216 S3 6 5
LOSARTAN POTASSIUM 201 196 7 13
WARFARIN SODIUM 197 194 8 12
METFORMIN HCL 187 163 9 8
GABAPENTIN 177 151 10 14
LEVOTHROID 164 161 11 44
AMLODIPINE BESYLATE 162 156 12 6
FUROSEMIDE 156 149 13 9
ATORVASTATIN CALCIUM 154 134 14 17
FAMOTIDINE 152 142 15 89
METOPROLOL TARTRATE 151 145 16 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 126 17 34
GLIPIZIDE 128 123 18 39
NORTRIPTYLINE HCL 124 120 19 100
OXYCODONE HCL 119 112 S2 20 24
LOVASTATIN 108 96 21 16
ALENDRONATE SODIUM 106 102 22 26
FLUTICASONE PROPIONATE 106 102 22 31
SPIRONOLACTONE 104 100 24 63
CITALOPRAM HBR 102 83 25 15
ADACEL 97 91 26 77
TRAZODONE HCL 96 89 27 21
ESTRADIOL 96 85 R 27 85
LEVOTHYROXINE SODIUM 93 90 29 3
TRIAMTERENE-HYDROCHLOROTHIAZID 91 91 30 103
PROAIR HFA 91 79 30 29
QVAR 89 85 32 115
HYDROCHLOROTHIAZIDE 85 76 33 7
FLUOXETINE HCL 84 74 34 33
PRAVASTATIN SODIUM 81 76 35 20
NOVOLIN 70-30 78 68 36 191
ALLOPURINOL 74 74 37 32
MORPHINE SULFATE ER 70 56 S2 38 36
PREDNISONE 67 65 39 38
TAMSULOSIN HCL 67 67 39 28
CLONIDINE HCL 65 65 41 92
INSULIN SYRINGE 62 55 42 91
TRIAMCINOLONE ACETONIDE 56 56 43 81
DOXYCYCLINE HYCLATE 53 50 44 201
DOXAZOSIN MESYLATE 52 52 45 76
NOVOLIN N 51 41 46 75
SPIRIVA 51 51 46 42
ACETAMINOPHEN-CODEINE 50 50 S3 48 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.